While the funding winter persists, the region’s fundamentals and strategic advantages have never been more compelling Read ...

Tears seem simple, but the tiny glands that produce them are among the least understood organs in the human body. By growing miniature human tear glands in the lab and coaxing them to “cry,” ...

When a house catches on fire, we assume that a smoke alarm inside will serve one purpose and one purpose only: warn the ...

SereNeuro Therapeutics revealed promising results for SN101, a first-in-class iPSC-derived therapy designed to treat chronic osteoarthritis pain while protecting joint tissue. Instead of blocking pain ...

A preclinical study uncovered a new gene therapy that targets pain centers in the brain while eliminating the risk of ...

MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss ...

Quarterly Nociscan scan volumes increased 114% year-over-year in Q4 2025Annual Nociscan scan volumes increased 69% year-over-year in 2025Debt-free balance sheet with $12.0 million in cash as of ...

Researchers at The University of Texas MD Anderson Cancer Center have discovered that targeting a specific immune process ...

A hidden immune stress switch may be driving chemotherapy nerve pain and scientists have found a way to turn it off.

Gene therapy ‘switch’ may offer non-addictive pain relief. New approach targets pain signals while leaving the rest of the brain untouched.

Researchers at USF Health have discovered a new way opioid receptors can work that may lead to safer pain medications. Their findings show that certain experimental compounds can amplify pain relief ...

While conventional medical treatments often focus on symptomatic relief, a growing interest is emerging in "biodecoding" – an alternative perspective that explores the emotional and psychological ...